Battle of the Bugs: Designing the Best Approach in the Fight Against Infectious Disease
more
PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
more
Antibacterial drugs: Clinical development for non-developers Part 1: Traditional development – tiers A and B
more
Coping with Preclinical Toxicology Challenges
more
Drug Discovery Data Insights: Highly Accessible SAR Data is Transforming the Drug Discovery Informatics Landscape
more
Alternatives to (classical) antibiotics: what will it take to convincingly develop a virulence inhibitor or similar indirect agent?
more
Decisions, Decisions: What Makes a Good Hit? A Good Lead? Why Do You Write a TPP? How Do You Write a TPP?
more
How Does a Molecule Become a Physical Medicine to be Given to a Human: The Importance of Chemistry, Manufacturing, and Controls
more
Michael Barbachyn
Professor, Brummel Chair in Organic Chemistry
Calvin College
more